Median Technologies SA (FRA:4ZG)

Market Cap	174.98M +477.5%
Revenue (ttm)	23.47M +2.2%
Net Income	-34.07M
EPS	-0.93
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	4.245
Previous Close	4.640
Day's Range	4.245 - 4.245
52-Week Range	1.282 - 6.420
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 16, 2026

About Median Technologies

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imagin...

• Industry: Computer Integrated Systems Design
• Founded: 2002
• Employees: 199
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4ZG

Financial Performance

In 2025, Median Technologies's revenue was 23.47 million, an increase of 2.22% compared to the previous year's 22.96 million. Losses were -34.07 million, 35.0% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error